Results
|
1.
|
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Catheterization & Cardiovascular Interventions. 92(7):E502-E511, 2018 Dec 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Alves Lemos P, Barbato E, BIOSOLVE-II and III investigators, Christiansen EH, Garcia-Garcia HM, Haude M, Ince H, Kische S, Tolg R, Van Mieghem NM, Verheye S, von Birgelen C, Waksman R
|
|
2.
|
Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography Study. MedStar authors:
Year: 2020
Citation: - Circulation: Cardiovascular Interventions. 13(3):e008657, 2020 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Byrne R, Garcia-Garcia HM, Haude M, Joner M, Koolen J, Landmesser U, Losdat S, Otsuka T, Raber L, Rai H, Ueki Y, Windecker S
|
|
3.
|
Too early to call. MedStar authors:
Year: 2012
Citation: - Cardiovascular Revascularization Medicine. 13(3):157-8, 2012 May-Jun.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
|
|
4.
|
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
Year: 2012
Citation: - The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
|